MarketCap
Facebook
X
TelegramQuarterly report 2025-Q2
added 08-08-2025
Surmodics Total Non Current Liabilities 2011-2026 | SRDX
Annual Total Non Current Liabilities Surmodics
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | 17.1 M | 20.4 M | 15.2 M | 15.9 M | 2.14 M | 2.07 M | 2.13 M | 2.43 M | 6.28 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 20.4 M | 2.07 M | 9.3 M |
Total Non Current Liabilities of other stocks in the Diagnostics research industry
| Issuer | Total Non Current Liabilities | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
23.7 M | - | -6.23 % | $ 30.6 M |  Germany |
 |
Agilent Technologies
A
|
3.29 B | $ 114.11 | 0.29 % | $ 34.7 B |  USA |
 |
Celcuity
CELC
|
69.2 K | $ 140.25 | -0.06 % | $ 6.56 B | USA |
 |
Co-Diagnostics
CODX
|
574 K | $ 4.13 | 72.81 % | $ 5.49 M | USA |
|
Akumin
AKU
|
527 M | - | -17.87 % | $ 25.9 M |  Canada |
 |
Castle Biosciences
CSTL
|
2.76 M | $ 20.63 | 3.0 % | $ 598 M | USA |
 |
Aspira Women's Health
AWH
|
3.49 M | - | -6.19 % | $ 10.5 M | USA |
 |
Accelerate Diagnostics
AXDX
|
134 M | - | -61.36 % | $ 2.46 M | USA |
 |
Fulgent Genetics
FLGT
|
2.26 M | $ 17.33 | 5.61 % | $ 524 M | USA |
 |
Biocept
BIOC
|
11.3 M | - | -13.05 % | $ 7.29 M | USA |
 |
Guardant Health
GH
|
91.4 M | $ 120.53 | 4.84 % | $ 15.1 B | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
7.74 M | - | - | $ 562 M |  Britain |
 |
CareDx, Inc
CDNA
|
17.9 M | $ 21.8 | 3.07 % | $ 1.16 B | USA |
 |
Chembio Diagnostics
CEMI
|
24.8 M | - | 0.22 % | $ 16.8 M | USA |
 |
Check-Cap Ltd.
CHEK
|
16 K | - | - | $ 9.42 M |  Israel |
 |
HTG Molecular Diagnostics
HTGM
|
4.1 M | - | -20.0 % | $ 1.06 M | USA |
 |
ICON Public Limited Company
ICLR
|
461 M | $ 115.87 | 0.68 % | $ 9.56 B |  Irlanda |
 |
Interpace Biosciences
IDXG
|
10 M | $ 1.8 | - | $ 7.96 M | USA |
 |
Illumina
ILMN
|
2.04 B | $ 143.06 | 0.8 % | $ 22.7 B | USA |
 |
Global Cord Blood Corporation
CO
|
2.53 B | - | - | $ 399 M |  China |
 |
Fluidigm Corporation
FLDM
|
131 M | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
559 K | - | - | $ 7.1 B |  Australia |
 |
Lantheus Holdings
LNTH
|
225 M | $ 95.21 | -0.92 % | $ 6.43 B | USA |
 |
Genetron Holdings Limited
GTH
|
48.5 M | - | 0.12 % | $ 80.1 M | China |
 |
DermTech
DMTK
|
865 K | - | -11.32 % | $ 2.94 M | USA |
 |
Charles River Laboratories International
CRL
|
2.35 B | $ 157.58 | 0.95 % | $ 7.81 B | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
1.43 B | - | - | $ 10.7 B | USA |
 |
Medpace Holdings
MEDP
|
73.8 M | $ 422.03 | 0.04 % | $ 12.2 B | USA |
 |
Enzo Biochem
ENZ
|
4.6 M | - | -8.98 % | $ 14.8 K | USA |
 |
Mettler-Toledo International
MTD
|
1.61 B | $ 1 082.7 | -0.04 % | $ 22.3 B |  Schweiz |
 |
NeoGenomics
NEO
|
435 M | $ 9.01 | 1.24 % | $ 1.15 B | USA |
 |
Exact Sciences Corporation
EXAS
|
981 M | - | - | $ 19.8 B | USA |
 |
National Research Corporation
NRC
|
39.6 M | $ 19.1 | -0.86 % | $ 428 M | USA |
 |
Natera
NTRA
|
124 M | $ 208.58 | 1.79 % | $ 20.5 B | USA |
 |
Myriad Genetics
MYGN
|
107 M | $ 3.78 | -0.79 % | $ 350 M | USA |
 |
Personalis
PSNL
|
639 K | $ 8.49 | 6.79 % | $ 758 M | USA |
 |
Heska Corporation
HSKA
|
57.9 M | - | - | $ 1.31 B | USA |
 |
Koninklijke Philips N.V.
PHG
|
8.45 B | $ 26.83 | 0.36 % | $ 25.4 B |  Niderland |
 |
Senseonics Holdings
SENS
|
163 M | $ 5.78 | 1.23 % | $ 241 M | USA |
 |
QIAGEN N.V.
QGEN
|
1.99 B | - | - | $ 10.6 B | Niderland |
 |
Soleno Therapeutics
SLNO
|
10.8 M | - | - | $ 2.69 B | USA |
 |
Biomerica
BMRA
|
1.57 M | $ 2.42 | 3.16 % | $ 5.56 M | USA |
 |
Thermo Fisher Scientific
TMO
|
22.5 B | $ 449.74 | -0.42 % | $ 170 B | USA |
 |
Laboratory Corporation of America Holdings
LH
|
7.82 B | $ 254.31 | -1.17 % | $ 21.2 B | USA |
 |
Twist Bioscience Corporation
TWST
|
4.56 M | $ 53.76 | 0.19 % | $ 3.22 B | USA |
 |
Trinity Biotech plc
TRIB
|
106 M | $ 0.62 | 1.89 % | $ 223 M | Irlanda |
 |
Motus GI Holdings
MOTS
|
2.16 M | - | -34.28 % | $ 263 K | Israel |
 |
Neogen Corporation
NEOG
|
19.6 M | $ 8.53 | -3.45 % | $ 1.85 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
5.17 B | $ 192.89 | -0.43 % | $ 21.4 B | USA |
 |
Invitae Corporation
NVTA
|
320 M | - | - | $ 21.2 M | USA |